American Vanguard Corp. (AVD) Shares Down 1.6%
Shares of American Vanguard Corp. (NYSE:AVD) fell 1.6% during mid-day trading on Wednesday . The stock traded as low as $14.45 and last traded at $14.64, with a volume of 135,774 shares trading hands. The stock had previously closed at $14.88.
Several research firms have issued reports on AVD. Zacks Investment Research upgraded American Vanguard Corp. from a “sell” rating to a “hold” rating and set a $14.00 price objective on the stock in a research note on Wednesday, May 4th. Roth Capital downgraded American Vanguard Corp. from a “buy” rating to a “neutral” rating and decreased their target price for the company from $19.00 to $14.50 in a research report on Wednesday, May 4th.
The company’s 50-day moving average is $14.33 and its 200-day moving average is $13.95. The stock has a market cap of $426.74 million and a P/E ratio of 45.05.
American Vanguard Corp. (NYSE:AVD) last released its quarterly earnings results on Tuesday, May 3rd. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.06 by $0.04. The company had revenue of $69.47 million for the quarter, compared to analyst estimates of $71.71 million. The company’s quarterly revenue was up 4.4% on a year-over-year basis. On average, analysts expect that American Vanguard Corp. will post $0.49 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 12th. Shareholders of record on Thursday, June 30th will be paid a dividend of $0.01 per share. The ex-dividend date of this dividend is Tuesday, June 28th. This represents a $0.04 dividend on an annualized basis and a yield of 0.27%.
In related news, insider Ulrich Trogele purchased 15,000 shares of the business’s stock in a transaction on Monday, May 9th. The stock was acquired at an average price of $13.25 per share, for a total transaction of $198,750.00. Following the purchase, the insider now owns 67,604 shares of the company’s stock, valued at $895,753. The transaction was disclosed in a filing with the SEC, which is available at this link.
A number of institutional investors recently added to or reduced their stakes in AVD. Robeco Institutional Asset Management B.V. increased its position in American Vanguard Corp. by 3.0% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 123,634 shares of the company’s stock worth $1,732,000 after buying an additional 3,634 shares during the period. Principal Financial Group Inc. increased its position in American Vanguard Corp. by 4.5% in the fourth quarter. Principal Financial Group Inc. now owns 168,899 shares of the company’s stock worth $2,366,000 after buying an additional 7,202 shares during the period. Bank of Montreal Can increased its position in American Vanguard Corp. by 3.4% in the fourth quarter. Bank of Montreal Can now owns 564,928 shares of the company’s stock worth $7,915,000 after buying an additional 18,471 shares during the period. Finally, Dimensional Fund Advisors LP increased its position in American Vanguard Corp. by 10.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,642,801 shares of the company’s stock worth $23,016,000 after buying an additional 160,412 shares during the period.
American Vanguard Corporation (AVD) operates as a holding company. The Company is primarily a specialty chemical manufacturer that develops and markets products for agricultural, commercial and consumer uses. It manufactures and formulates chemicals for crops, human and animal protection. It conducts its business through its subsidiaries, which include AMVAC Chemical Corporation (AMVAC), GemChem, Inc, 2110 Davie Corporation, Quimica Amvac de Mexico SA de C.V., AMVAC Mexico Sociedad de Responsabilidad Limitada, AMVAC de Costa Rica Sociedad de Responsabilidad Limitada, AMVAC Switzerland GmbH, AMVAC do Brasil Representacoes Ltda, AMVAC CV, AMVAC Netherlands BV and Envance Technologies, LLC.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.